CN105935396A - 一种治疗胆囊炎的芦荟膏 - Google Patents

一种治疗胆囊炎的芦荟膏 Download PDF

Info

Publication number
CN105935396A
CN105935396A CN201610362752.1A CN201610362752A CN105935396A CN 105935396 A CN105935396 A CN 105935396A CN 201610362752 A CN201610362752 A CN 201610362752A CN 105935396 A CN105935396 A CN 105935396A
Authority
CN
China
Prior art keywords
aloe
ointment
spica prunellae
starch
rhizoma polygoni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610362752.1A
Other languages
English (en)
Inventor
朱胜利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610362752.1A priority Critical patent/CN105935396A/zh
Publication of CN105935396A publication Critical patent/CN105935396A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

本发明涉及一种治疗胆囊炎的芦荟膏，芦荟膏的活性成分来源于下列重量配比的原料：芦荟110‑135g、淀粉120‑135g、绿豆15‑21g、金钱草13‑18g、通草13‑18g、夏枯草13‑18g、连翘15‑20g、猪苦胆4‑9g、虎杖7‑12g；将所述原料中绿豆烘焙熟透后磨粉，将金钱草、通草、夏枯草、连翘、猪苦胆、虎杖按总重量加水2～2.2倍，煎熬两次，取煎熬所得的煎液与芦荟、淀粉、绿豆粉混合制成膏状；本发明将金钱草、通草、夏枯草、连翘、猪苦胆、虎杖等用于治疗胆囊炎的中药材与淀粉、绿豆、芦荟一起制作成芦荟膏，利用这些中药材的药效和芦荟、绿豆清热祛除、去腻生津的功效，增强治疗效果，安全无副作用，而且改善药品的服用方式，提升治疗体验。

Description

一种治疗胆囊炎的芦荟膏
技术领域
本发明涉及医药保健品领域，具体是一种治疗胆囊炎的芦荟膏。
背景技术
众所周知，胆囊炎是细菌性感染或化学性刺激(胆汁成分改变)引起的胆囊炎性病变，为胆囊的常见病。在腹部外科中其发病率仅次于阑尾炎，本病多见于35-55岁的中年人，女性发病较男性为多，尤多见于肥胖且多次妊娠的妇女。胆囊炎分为急性和慢性两种。急性胆囊炎会引起右上腹疼痛，一开始疼痛与胆绞痛非常相似，但急性胆囊炎引起的腹痛其持续的时间往往较长，作呼吸和改变体位常常能使疼痛加重。而慢性胆囊炎是最常见的一种胆囊疾病。慢性胆囊炎有时可为急性胆囊炎的后遗症，但大多数病人过去并没有患过急性胆囊炎。由于胆囊长期发炎，胆囊壁会发生纤维增厚，疤痕收缩，造成胆囊萎缩，囊腔可完全闭合，导致胆囊功能减退，甚至完全丧失功能。
发明内容
本发明为了克服现有技术中的不足，提供了一种治疗胆囊炎的芦荟膏，在本发明中用于胆囊发炎治疗，尤其适用于慢性胆囊炎的治疗，治疗效果好。
本发明是通过以下技术方案实现：
一种治疗胆囊炎的芦荟膏，芦荟膏的活性成分来源于下列重量配比的原料：芦荟110-135g、淀粉120-135g、绿豆15-21g、金钱草13-18g、通草13-18g、夏枯草13-18g、连翘15-20g、猪苦胆4-9g、虎杖7-12g。
作为本发明的优选技术方案，所述芦荟膏的活性成分来源于下列重量配比的原料：芦荟115-130g、淀粉125-130g、绿豆17-19g、金钱草15-17g、通草15-17g、夏枯草15-17g、连翘17-19g、猪苦胆6-8g、虎杖9-11g。
作为本发明的优选技术方案，所述芦荟膏的活性成分来源于下列重量配比的原料：芦荟122g、淀粉127g、绿豆18g、金钱草16g、通草16g、夏枯草16g、连翘18g、猪苦胆7g、虎杖10g。
所述芦荟去除外皮，取用其中的芦荟肉。
与现有的技术相比，本发明的有益效果是：本发明将金钱草、通草、夏枯草、连翘、猪苦胆、虎杖等用于治疗胆囊炎的中药材与淀粉、绿豆、芦荟一起制作成芦荟膏，利用这些中药材的药效和芦荟、绿豆清热祛除、去腻生津的功效，增强治疗效果，安全无副作用，而且改善药品的服用方式，提升治疗体验。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
芦荟含有大量的氨基酸、维生素、多糖类化合物，各种酶和矿物质，具有杀菌消炎、增强免疫功能、清除内毒素和自由基的作用，能解除便秘、预防结肠炎，改善血液循环，祛痘养颜，且芦荟清热祛除、去腻生津的功效，增进全身健康。健康人的体液是碱性的，常服芦荟制品能使体液维持碱性，保持健康体质。
本发明为一种治疗胆囊炎的芦荟膏，芦荟膏的活性成分来源于下列重 量配比的原料：芦荟110-135g、淀粉120-135g、绿豆15-21g、金钱草13-18g、通草13-18g、夏枯草13-18g、连翘15-20g、猪苦胆4-9g、虎杖7-12g；
将所述原料中绿豆烘焙熟透后磨粉，将金钱草、通草、夏枯草、连翘、猪苦胆、虎杖按总重量加水2～2.2倍，煎熬两次，取煎熬所得的煎液与芦荟、淀粉、绿豆粉混合制成膏状。
作为本发明的一个较佳实施例，所述芦荟膏的活性成分来源于下列重量配比的原料：芦荟115-130g、淀粉125-130g、绿豆17-19g、金钱草15-17g、通草15-17g、夏枯草15-17g、连翘17-19g、猪苦胆6-8g、虎杖9-11g。
作为本发明的一个较佳实施例，所述芦荟膏的活性成分来源于下列重量配比的原料：芦荟122g、淀粉127g、绿豆18g、金钱草16g、通草16g、夏枯草16g、连翘18g、猪苦胆7g、虎杖10g。
所述芦荟去除外皮，取用其中的芦荟肉。
所述绿豆在135-140℃下烘焙13-15分钟，然后磨粉。
所述金钱草、通草、夏枯草、连翘、猪苦胆、虎杖加水后煎熬2.5-3小时。作为优选，所述金钱草、通草、夏枯草、连翘、猪苦胆、虎杖加水后煎熬2.8小时。
为方便保存和服用，所述芦荟膏采用真空包装袋分装。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。

Claims (4)

1.一种治疗胆囊炎的芦荟膏，其特征在于：芦荟膏的活性成分来源于下列重量配比的原料：芦荟110-135g、淀粉120-135g、绿豆15-21g、金钱草13-18g、通草13-18g、夏枯草13-18g、连翘15-20g、猪苦胆4-9g、虎杖7-12g。
2.根据权利要求1所述的一种治疗胆囊炎的芦荟膏，其特征在于：所述芦荟膏的活性成分来源于下列重量配比的原料：芦荟115-130g、淀粉125-130g、绿豆17-19g、金钱草15-17g、通草15-17g、夏枯草15-17g、连翘17-19g、猪苦胆6-8g、虎杖9-11g。
3.根据权利要求2所述的一种治疗胆囊炎的芦荟膏，其特征在于：所述芦荟膏的活性成分来源于下列重量配比的原料：芦荟122g、淀粉127g、绿豆18g、金钱草16g、通草16g、夏枯草16g、连翘18g、猪苦胆7g、虎杖10g。
4.根据权利要求1所述的一种治疗胆囊炎的芦荟膏，其特征在于：所述芦荟去除外皮，取用其中的芦荟肉。
CN201610362752.1A 2016-05-26 2016-05-26 一种治疗胆囊炎的芦荟膏 Withdrawn CN105935396A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610362752.1A CN105935396A (zh) 2016-05-26 2016-05-26 一种治疗胆囊炎的芦荟膏

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610362752.1A CN105935396A (zh) 2016-05-26 2016-05-26 一种治疗胆囊炎的芦荟膏

Publications (1)

Publication Number Publication Date
CN105935396A true CN105935396A (zh) 2016-09-14

Family

ID=57152286

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610362752.1A Withdrawn CN105935396A (zh) 2016-05-26 2016-05-26 一种治疗胆囊炎的芦荟膏

Country Status (1)

Country Link
CN (1) CN105935396A (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1824264A (zh) * 2005-12-18 2006-08-30 王亚儒 一种治疗胆囊炎的外用膏剂
CN103719333A (zh) * 2012-10-12 2014-04-16 钱国祥 一种红小豆胆囊炎保健茶
CN103830657A (zh) * 2012-11-26 2014-06-04 李志娜 一种治疗慢性胆囊炎的药物
CN104547297A (zh) * 2014-12-09 2015-04-29 李国华 一种治疗胆囊炎药物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1824264A (zh) * 2005-12-18 2006-08-30 王亚儒 一种治疗胆囊炎的外用膏剂
CN103719333A (zh) * 2012-10-12 2014-04-16 钱国祥 一种红小豆胆囊炎保健茶
CN103830657A (zh) * 2012-11-26 2014-06-04 李志娜 一种治疗慢性胆囊炎的药物
CN104547297A (zh) * 2014-12-09 2015-04-29 李国华 一种治疗胆囊炎药物

Similar Documents

Publication Publication Date Title
CN102961525A (zh) 一种用于减肥、辅助降血脂的药物组合物及其口服液制备方法
CN101926882A (zh) 治疗癌症的药物组合物及其制备方法
CN105935396A (zh) 一种治疗胆囊炎的芦荟膏
CN104757536A (zh) 恰玛古保健品
CN101766666A (zh) 治疗心脑血管疾病的中药
CN105647747A (zh) 一种四味调经止带保健养生药酒配方
CN107281355A (zh) 一种用于乳腺堵塞、乳房发育不良、乳腺增生的制剂
CN106617053A (zh) 一种防治前列腺炎及前列腺增生的保健食品及制备方法
CN102614365B (zh) 一种用于治疗乳腺肿瘤的中药组合物
CN106038871A (zh) 一种治疗胆囊炎的芦荟膏的制备方法
CN105998457A (zh) 一种优化治疗胆囊炎的芦荟膏的制备方法
CN102188644B (zh) 一种治疗癌症的中药
CN102078533B (zh) 一种治疗高血压的药物
CN104770501A (zh) 一种治疗便秘的养生茶叶及其加工方法
CN111419983B (zh) 滋肾养血膏剂
CN103142928A (zh) 骨筋口服液及其制备方法
CN102755444A (zh) 一种用于治疗高血脂症的中药组合物及其制备方法
CN106421665A (zh) 一种复方中药组合物在制备提高人体免疫力药物中的应用
CN105920497A (zh) 一种用于治疗胃病的药物及制备方法
CN105853882A (zh) 一种用于治疗胃病的药物及制备方法
CN1326548C (zh) 一种治疗淋病的药物
CN105194577A (zh) 一种治疗乳腺增生的药剂
CN103070994A (zh) 一种治疗颈椎腰椎病的膏药
CN105056098A (zh) 一种治疗腰痛的药物
CN104510989A (zh) 一种治疗病毒性心肌炎的中药

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20160914